ABX-CRO Advanced Pharmaceutical Services m.b.H. (ABX-CRO)

ABX-CRO is a globally operating clinical research organization with a strong focus on pre-clinical and clinical molecular imaging and molecular radiotherapy, which was established in 2002 as a privately held independent full service CRO. Based on over 15 years of experience in diagnostic and therapeutic oncology, neurology and other disease areas, ABX-CRO provides unique opportunities to test drug candidates in complex pre-clinical disease models, assessed quantitatively using molecular and functional imaging (PET, SPECT, CT, MRI). Translating pre-clinical results into First in Man studies and supporting design and execution of efficient late stage clinical trials, ABX-CRO makes translational medicine a visible reality.

Go back

HYBRID2020 Consortium |
© All Rights Reserved Imprint & Data Policy